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The process of neurogenesis, through which the entire nervous system of an organism is
formed, has attracted immense scientific attention for decades. How can a single neural
stem cell give rise to astrocytes, oligodendrocytes, and neurons? Furthermore, how is
a neuron led to choose between the hundreds of different neuronal subtypes that the
vertebrate CNS contains? Traditionally, niche signals and transcription factors have been
on the spotlight. Recent research is increasingly demonstrating that the answer may
partially lie in epigenetic regulation of gene expression. In this article, we comprehensively
review the role of post-translational histone modifications in neurogenesis in both the
embryonic and adult CNS.
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INTRODUCTION
Histone post-translational modifications (PTMs) have been implicated in a multitude of
developmental processes and diseases (Bhaumik et al., 2007; Chi et al., 2010; Tyssowski et al.,
2014; Yao and Jin, 2014). Throughout the last decade, interest into the role of histone PTMs in
neurogenesis has risen. The goal of this review is to provide an overview of the current evidence for
histone PTM involvement in neurogenesis, the known mechanisms that initiate these processes, as
well as investigate the contribution of histone PTMs to the complex and interconnected network
of epigenetic modifications. We begin with a brief introduction into neurogenesis and histone
PTMs, then move on to discuss the major histone PTMs (i.e., acetylation and methylation) that
have been investigated in the context of neurogenesis, highlighting a few studies that exemplify the
main conceptual insight. Lastly, we discuss how these processes are initiated and how specificity is
achieved.
Neurogenesis
Neurogenesis in vertebrates begins after ectodermal cells acquire a neuroepithelial identity through
the process of induction and subsequent morphological transformation to become radial “glial”
cells with stem cell properties (Dang and Tropepe, 2006; Kriegstein and Alvarez-Buylla, 2009).
Neuroepithelial cells, followed by radial glial cells, undergo a period of population expansion
before radial glial cells differentiate into committed transit amplifying progenitors (Figure 1) that
eventually give rise to mature cells of the central nervous system (CNS). Through a cell intrinsic
clock, these neural stem cells initially differentiate into neurons and switch their competence toward
generating astrocytes (Miller andGauthier, 2007), as depicted in Figure 1. Oligodendrocytes are the
last fate to arise and are typically generated during post-embryonic stages. Interestingly, isolated
neural stem cells from the embryonic cerebral cortex follow the same order of differentiation
in vitro, initially giving rise to neurons and then astrocytes (Qian et al., 2000). The mechanism
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FIGURE 1 | Embryonic neuroepitethial (NE) cells of the neural tube give rise to radial glial cells, which through an intrinsic clock differentiate first into
neurons and then into astrocytes. The neurogenesis “window” extends approximately from E11 to E18. nIPC, neurogenic intermediate progenitor cell; oIPC,
oligodendrogenic intermediate progenitor cell. Note that no oligodendrocytes are generated before birth. The figure represents embryonic neurogenesis in the mouse.
Adapted from Kriegstein and Alvarez-Buylla (2009).
by which this intrinsic clock is established, which is common
among most developing neural tissues, has been a long lasting
question in developmental neurobiology.
Neurogenesis persists in adulthood with notable species
variation, but is typically limited to specific neurogenic regions
that can be associated with functional plasticity and regeneration
(Lindsey and Tropepe, 2006; Ming and Song, 2011; Kaslin
et al., 2013). Although adult neural stem cells share most
characteristics with their embryonic counterparts, such asmarker
expression and multipotentiality in vitro (Reynolds and Weiss,
1992; Weiss et al., 1996), they are typically restricted under
physiological conditions producing primarily neurons in vivo
(Alvarez-Buylla and Nottebohm, 1988; Grandel et al., 2006;
Lledo et al., 2008). Thus, while the process of neurogenesis
is fundamentally conserved among brain regions, ontogeny
and putatively throughout vertebrate evolution, neurogenesis
is nonetheless shaped by significant adaptations to distinct
physiological states and life histories (Tropepe, 2008).
Factors that influence the extent of neurogenesis include
proliferation and survival of neural stem and progenitor cells
(NSPCs), their efficiency of differentiation into neurons and glial
cells, and the survival and function of the differentiated progeny.
The term NSPCs is used when neural stem cell identity cannot be
readily distinguished from that of a more committed progenitor
cell identity.
Histone Post-Translational Modifications
The nucleosome, a fundamental unit of chromatin, consists
of 146–147 bp of DNA that is wrapped around 1 histone
octamer, which includes 2 molecules of each of the core histones
H2A, H2B, H3, and H4 (Kouzarides, 2007). In the last two
decades it has become increasingly evident that nucleosomes
have a broader role than just facilitating the packaging of DNA
into the tiny space that is a cell nucleus. Histones participate
in the regulation of gene expression and are the target of a
plethora of transcription factors or associated proteins. The
histone N-termini that protrude from the tightly packed octamer,
are somewhat less structured (Kouzarides, 2007; Bannister and
Kouzarides, 2011). They are free to interact with DNA, and are
also exposed to modification enzymes. These enzymes modify
histone N-termini by, for instance acetylation, methylation,
phosphorylation, SUMOylation, ubiquitination, citrullination, or
ribosylation (Tan et al., 2011). Each of these modifications has
an effect on gene expression through 2 potential mechanisms.
The first one is based on electrostatic interactions (Zentner
and Henikoff, 2013). Specifically, DNA is negatively charged
and histone N-termini are positively charged. Depending on
the modification, the positive charge of the N-terminus may
be concealed or exposed. For example, acetylation of a lysine
residue will mask its positive charge and prevent strong attraction
to the DNA. This will lead to a more relaxed chromatin state,
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and when this occurs in a promoter, transcription factors have
more room to bind DNA and exert their functions. The converse
would happen in the case of histone deacetylation at a lysine
residue. The second major mechanism of action of chromatin
modifications is through creating binding sites for transcription
factors and adaptor proteins that recognize specifically modified
histone residues (Bannister and Kouzarides, 2011; Zentner and
Henikoff, 2013).
While histone PTM is a major contributor to epigenetic
regulation of gene expression, it is important to keep in mind
that it represents only one aspect of an ever-expanding network
of epigenetic regulators (Yao and Jin, 2014). Epigenetics can be
loosely defined as changes in gene expression, or the phenotype,
that are not induced by changes in the DNA sequence (Bird,
2007). In addition to histone PTMs, a long list of regulatory
mechanisms of gene expression fit under this term including
DNA methylation, microRNAs, long non-coding RNAs and
methyl-DNA binding proteins. In reality, the various epigenetic
mechanisms co-operate and form complexes or groups of
enzymes in which there is a cascade of signals linking an
extracellular trigger to a gene expression event (Jobe et al., 2012).
HISTONE PTMS IN NEUROGENESIS
Histone Acetylation
Histone acetylation was the first histone PTM to be discovered
as well as associated with gene expression (Phillips, 1963; Allfrey
et al., 1964). Histones are acetylated at lysine residues by histone
acetyl-transferases (HATs) and are deacetylated by histone
deacetylases (HDACs) (Bannister and Kouzarides, 2011). The
involvement of histone acetylation in neurogenesis is widespread
and ranges from embryonic neurogenesis, to adult neuronal
survival and differentiation. Below we describe, using selected
examples, how histone acetylation could influence the process of
neurogenesis.
CREB/CBP and Their Roles in Neurodevelopment
and Neurodegeneration
One of the initial culprits to be identified was c-AMP responsive
element binding protein (CREB) (Montminy and Bilezikjian,
1987; Lonze and Ginty, 2002; Dworkin and Mantamadiotis,
2010). CREB is a generic transcriptional activator that is involved
in a plethora of developmental processes as well as cancer,
and it functions by recruiting CREB-binding protein (CBP or
CREBBP), which possesses HAT activity (Chrivia et al., 1993).
CREB function has been implicated in neuronal plasticity,
hippocampal learning and memory (Bailey et al., 1996), partially
by regulating the secretion of the growth factor BDNF (Tao
et al., 1998). Various reports have also shown that CREB is
involved in both embryonic and adult neurogenesis (Young et al.,
1999; Zhu et al., 2004). CREB knockout mice (Dworkin et al.,
2009) analyzed at E14.5 display severe deformities in both their
embryonic brain and retina, sometimes completely lacking an
olfactory bulb. Additionally, embryonic NSPCs from CREB−/−
mice show decreased survival in vitro, but normal differentiation
(Dworkin et al., 2009). Investigating the mechanism, the authors
identified that the transcripts for the anti-apoptotic protein
bcl-2 and the growth factors BDNF, NGF and PACAP were
decreased in CREB −/− NSPC cultures. Interestingly, analyzing
CREB−/− mice at E18.5, Rudolph et al. (1998) reported only
subtle morphological alterations of the brain structure. This
indicates that CREB loss of function could delay the neurogenesis
“window” so that obvious deformities exist at early stages but
might be compensated for at later stages in development. An
alternative explanation for these seemingly conflicting results
could be based on the cAMP response element regulatory protein
(CREM). CREM belongs to the CREB family of transcription
factors and is known to compensate for the lack of CREB
(Hummler et al., 1994; Mantamadiotis et al., 2002). In the report
by Rudolph et al., there was a strong upregulation of CREM
upon CREB knockout at E18.5, which was not observed by
Dworkin et al. at E14.5. This, along with observations in very
early CREB−/− embryos (Bleckmann et al., 2002) may suggest
that the complementation of CREB function by CREMmay only
occur at time points later than E14.5. In order to overcome
this functional redundancy issue, Mantamadiotis et al. (2002)
generated conditional CREB knockout mice on a CREM−/−
background. When the deletion was driven by Nestin-Cre,
therefore occurring in NSPCs, there was a decrease in brain size
with differences becoming obvious from E16.5 onwards, which
coincided with the onset of strong CREB deletion. The cortex
and the hippocampus were the most strongly affected areas, and
mice died perinatally. The phenotype was attributed to increased
apoptosis in the affected areas. Interestingly, when CREB deletion
was driven by the promoter of calcium/calmodulin-dependent
protein kinase II-α (CamkIIα) gene to drive expression in
mature neurons postnatally, a progressive neuronal degeneration
over the course of 6 months was observed. The areas mostly
affected were the hippocampus and the striatum and the animals
exhibited a behavioral phenotype reminiscent of models of
neurodegenerative disease (Lalonde, 1987; Mangiarini et al.,
1996; van den Akker et al., 1999; Dragatsis et al., 2000; Yamada
et al., 2001). Therefore, these studies demonstrated that histone
acetylation triggered by CREB is necessary for neurogenesis both
at the NSPC and the mature neuron level.
Notably, histone acetylation has also been implicated in
neurodevelopmental disorders. Rubinstein-Taybi syndrome is
characterized by cognitive dysfunction, and caused by a
haploinsufficiency in the cbp (encoding for CBP) gene (Roelfsema
and Peters, 2007). Cbp+/− mice show cognitive impairment in
adulthood, which gave rise to the hypothesis that the effect is due
to defective neural circuits (Josselyn, 2005). Wang et al. (2010)
demonstrated that cbp+/− mice also show deficits in embryonic
neurogenesis and gliogenesis. Cbp+/− pups displayed an altered
frequency, duration and number of ultra-sonic vocalizations
(USV) after separation from their mothers. USV changes are
believed to reflect cognitive and social behavior impairments
(Branchi et al., 2001). Embryonic neural precursors differentiated
into all three lineages (neurons, astrocytes, oligodendrocytes)
with less efficiency both in vitro and in vivo, when CBP was
knocked down. The HAT activity of CBP was necessary for
that effect, since an HDAC inhibitor could rescue the effects
of the CBP knockdown. CBP was shown to directly bind and
acetylate the H3K9/14 at promoters of genes involved in neural
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(βIII-tubulin), astrocytic (GFAP, S100β) and oligodendrocytic
(MBP, PLP2) development, thus up-regulating their expression.
Moreover, the accessibility of HDACs andCBP to gene promoters
involved in NSPC specification in the zebrafish hindbrain is
regulated by the interaction of Meis and Pbx transcription factors
(Choe et al., 2009). This indicates that transcription factors
can act as gatekeepers, or conversely molecular beacons, for
HDAC/HAT recruitment in a region specific manner. Lastly, the
phosphorylation of CBP by atypical protein kinase C ζ (aPKCζ)
was shown to be necessary for promoting the differentiation
of neural precursors, and has been linked to spatial memory
formation (Wang et al., 2010, 2012). The latter provides a
functional link between CBP function and extracellular signals
that are known to be involved in neurogenesis, such as
fibroblast growth factors (FGFs) and neurotrophins (Kengaku
and Okamoto, 1993; Bartkowska et al., 2007), and may pave the
way to new approaches for treatment of various neurological
disorders.
Histone Acetylation and Neuronal Differentiation: The
Case of Orexin Neurons
Histone acetylation appears to also be involved in the
differentiation of specific neuronal subtypes. Hayakawa et al.
(2013) showed that the differentiation of orexin neurons from
mouse embryonic stem (ES) cells depends on DNA methylation
and histone acetylation. Orexin neurons are localized in the
hypothalamus and are involved in the sleep/wake cycles as well
as feeding behavior. Orexin neuron differentiation requires the
expression of hypocretin (orexin) neuropeptide precursor (Hcrt),
which contains two proximal regulatory regions that are CpG
island-rich. The authors demonstrated that mES cells, as well as
neurons derived from mES cells under standard differentiation
conditions had high DNA methylation at these regions, as well
as low histone acetylation at various lysine residues, which
translates to low gene expression. On the contrary, treatment
with N-acetyl-D-mannosamine (ManNAc) induced an increase
in histone acetylation at all of the assessed sites. The authors
proceeded to pinpoint that Sirt1, a class III HDAC, inhibited
orexin neuron differentiation. They finally demonstrated that
meningioma-expressed antigen 5 (Mgea5) was necessary for the
effect of ManNAc into orexin neuron differentiation. Mgea5 has
a dual enzymatic activity: it is a HAT and also serves as an O-
GlcNAcase, which removes O-linked N-acetyl glycosamine (O-
GlcNAc) residues from proteins including histones. Interestingly,
both enzymatic activities were required for orexin neuron
differentiation. This observation led to a model (Figure 2),
whereby in non-orexin neurons, the Hcrt regulatory regions have
deacetylated histones and are O-GlcNAc rich. In orexin neurons,
Mgea5 expression leads to removal of the O-GlcNAc residues
and acetylation of core histones, which induces the expression
of Hcrt. The substrate of the O-GlcNAcylation remains to be
defined, even though core histones are a probable candidate
(Sakabe et al., 2010; Fujiki et al., 2011; Fong et al., 2012).
Region and Cell-Type Specific Differences in
Neurogenesis
The histone code of neurogenesis is not universal. Different areas
of the central nervous system can be differentially affected by the
FIGURE 2 | Epigenetic regulation of orexin neuron differentiation. In embryonic stem cells as well as non-orexin neurons, SIRT1 deacetylates the histones at
the regulatory region of the HCRT gene, leading to repression of its expression. These histones also contain O-GlcNAc residues. Treatment with ManNAc activates
Mgea5, which acetylates the histones of the HCRT regulatory region, and leads to removal of the GlcNAc residues. This activates the expression of the HCRT gene,
and the cells turn into orexin neurons.
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same histone modification. Shakèd et al. (2008) demonstrated
that HDACs of classes I and II are necessary for neurogenesis
in the embryonic ganglionic eminence, but inhibit neurogenesis
in the embryonic cortex. The results held true both in vitro
and in vivo. The authors used Trichostatin A (TSA), a chemical
inhibitor of class I and II HDACs (Yoshida et al., 1990). The
mechanism of the observed effect was shown to involve the
BMP2/4 pathway, which induces neurogenesis in the cortex but
promotes astrogliogenesis in other areas of the brain (Gross
et al., 1996; Li et al., 1998; Lim et al., 2000). In studies assessing
the effects of HDAC inhibition on mature neuronal survival,
Forgione et al. (Forgione and Tropepe, 2011, 2012) found that
treatment of cells isolated from the embryonic mouse ventral
midbrain with the HDAC inhibitors TSA, valproic acid (VPA)
or sodium butyrate (SB) induced cell death in neurons but not
astrocytes and the cell death was largely caspase-independent.
Intriguingly, the same treatment did not result in neuronal cell
death in cultures from the embryonic cortex. These studies
underline the complexity of the epigenetic regulatory network of
neurogenesis and indicate that a one-size-fits-all model might not
be entirely correct. We will describe and discuss some of these
aspects in the following sections.
Lessons Learned from HDAC Inhibitor Experiments
Chemical inhibitors of global HDAC function such as TSA,
VPA and SB have been used to investigate the role of histone
acetylation in neurogenesis and yielded somewhat conflicting
results.
Hsieh et al. assessed the levels of acetylated histones H3
and H4 during adult rat hippocampal NSPC differentiation
into neurons, astrocytes and oligodendrocytes and found
that neuronal differentiation was associated with a greater
maintenance of acetyl-H3 and acetyl-H4 than differentiation into
the other 2 lineages (Hsieh et al., 2004). They proceeded to show
that treatment with VPA increased neuronal differentiation of
these NSPCs at the expense of glial differentiation, and confirmed
the results using the HDAC inhibitors TSA and SB. The effect
was attributed to induction of NeuroD1, a known transcription
factor involved in neurogenesis (Miyata et al., 1999), by the VPA
treatment. Intriguingly, VPA treatment led to 3 times as much
cell death as in control cultures, which implies that selective
survival of neuronal progenitor cells could also be involved.
VPA treatment in vivo also decreased BrdU incorporation and
increased neuronal differentiation in the hippocampus of adult
rats, which supports the in vitro observations. Corroborating the
study of Hsieh et al. (Yu et al., 2009) also observed decreased
BrdU incorporation in hippocampal neural stem cells after VPA
treatment, and increased differentiation both in vitro and in vivo.
On the contrary, Hao et al. (2004) showed that VPA treatment
of adult mice led to an increase in BrdU incorporation in
the hippocampus. Furthermore, Kim et al. (2009) found that
administration of the HDAC inhibitors SB or TSA after ischemic
hypoxia increased the BrdU incorporation and the Ki67 staining
in the forebrain neurogenic zones of adult rats. In addition,
PSA-NCAM staining was augmented with the treatments, which
indicates that HDAC inhibition resulted in an increase in the
presence of neuronal progenitors and/or immature neurons.
An increase in the number of BrdU+ cells typically indicates
increased proliferation of the NSPCs. However, the state of
the cell cycle of NSPCs is an important consideration when
interpreting BrdU incorporation data. For example, an in vitro
study by Zhou et al. (2011) demonstrated that neural stem
cells from the forebrain subependymal zone of adult mice
exhibited a G1-to-S cell cycle arrest upon treatment with SB
or suberoylanilide hydroxamic acid (SAHA), another HDAC
inhibitor. If cells treated with HDAC inhibitors are gradually
prolonging their cell cycle toward eventual cell cycle exit, then
there could be a period of increased numbers of BrdU+ cells
before they undergo differentiation or cell death. The study by
Zhou et al. (2011) showed that neuronal specification genes
such as NeuroD1, Neurogenin 1 and cell cycle inhibitors such
as p21 and p27 were up-regulated with the treatments while
progenitor associated genes, such as Sox2 and the Notch effectors
Hes1 and Hes5 were down-regulated, suggesting that these cells
prematurely differentiated into neurons.
In general, these studies suggest that chemically inhibiting
HDACs may alter the behavior of NSPCs in the adult brain.
In some cases this could lead to a prolonging of the cell cycle
prior to exit or it could lead to premature cell cycle exit and
this could depend on the type NSPC or other factors. Ultimately,
HDAC inhibition seems to facilitate neuronal differentiation
from progenitor cells, but also cause cell death if the inhibition
is prolonged after neurons have differentiated. One caveat is the
potential for off-target effects and toxicity when using chemical
inhibitors (Marks et al., 2003; Wang et al., 2009; Forgione
and Tropepe, 2011; Sun et al., 2011). Additionally, HDACs
are enzymes of broad specificity that often target and remove
acetyl-groups from transcription factors and other non-histone
proteins. Therefore, the observed phenotype could be a result of
these non-histone effects, which makes the data interpretation
difficult.
Another explanation may be cell-specific expression of
HDACs. Spatial and temporal variations in levels of expression of
individual HDACs in different cell types and/or different stages
of development should affect the genome wide occupancy of
the HDACs. A pan-inhibition of several types of HDACs could
therefore have different and even opposite effects in progenitors
from different regions and at different stages of maturation. It is
therefore important to elucidate roles for specific HDACs in vivo
and in vitro.
Lessons Learned from Experiments Using
Knockdowns of Specific HDACs
Genetic knockout studies have enabled us to further decipher the
role of specific HDACs, as well as interactions between different
HDACs, in regulating neurogenesis. Conditional knockouts of
HDAC1 and HDAC2 driven by GFAP-cre, which is expressed
in neural stem cells and astrocytes, revealed that their functions
are redundant (Montgomery et al., 2009). When either HDAC1
or HDAC2 were missing, no obvious phenotype was observed.
The double knockout mice, in contrast, showed severe structural
abnormalities in the cortex, hippocampus and cerebellum and
died within the first postnatal week. When E14.5 cortical NSPCs
were cultured in vitro, the double knockout cells exhibited
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an almost complete blockade of neuronal differentiation, while
the astrocytic differentiation was unaffected. The phenotype
was attributed to increased apoptosis of neuronal progenitors
both in vitro and in vivo, but could also be explained by a
lack of maintenance of the differentiated neuronal state in the
absence of HDAC1/2 function consistent with the effects of
HDAC inhibitors on relatively mature neurons in vitro (Forgione
and Tropepe, 2011). Therefore, this report unequivocally
demonstrated that HDAC1 and HDAC2 are necessary for
proper embryonic neurogenesis, and is in agreement with
results obtained using dominant negative HDAC1 or HDAC2
(Humphrey et al., 2008). In addition, specific roles for HDAC2
in oligodendrocyte differentiation and HDAC3 in neuronal
differentiation linked to acetylation of lysine 14 visavi 9 on
histone H3 (H3K14, H3K9) were suggested based on RNA
knockdown studies in rat embryonic cortical progenitors in vitro
(Castelo-Branco et al., 2014). An important lesson from all
of these studies is that global inhibition of HDACs can mask
the contributions of individual HDACs to neurogenesis leading
to conflicting observations especially when comparing different
experimental contexts. Nonetheless, it is equally apparent that
the regulation of histone deacetylation occurs at multiple levels
and includes the specific subtype of HDAC, the specific cell
type involved, as well as the region of the brain in which
the deacetylation is occurring. The intersections between these
complex levels of regulation no doubt enable the fine-tuning of
neurogenesis, yet the details of these processes remain obscure.
Histone Methylation
In addition to histone acetylation, another PTM that was
discovered in the 1960’s is histone methylation (Allfrey et al.,
1964). Histone methylation used to be considered an irreversible
mark, in stark opposition to the dynamic nature of histone
acetylation, but the discovery of histone demethylases has
altered that view (Shi et al., 2004; Cloos et al., 2008;
Bannister and Kouzarides, 2011). Histone methylation can
occur at lysine or arginine residues. Lysine methylation is
catalyzed by histone methyl-transferases (HMT), and lysines
can be mono-, di- or tri-methylated. The number of methyl-
groups added can alter the resulting phenotype. Arginine
methylation is catalyzed by protein arginine methyl-transferases
(PRMT), and can lead to mono-methylated, symmetrically di-
methylated, or asymmetrically di-methylated arginines. Unlike
histone acetylation, the effects that methylation has on gene
expression depend on the specific residue that gets modified.
For example, trimethylation of the lysine 4 residue of histone 3
(H3K4) is considered a mark of transcriptional activation, while
trimethylation of H3K27 is a mark of transcriptional repression
(Schuettengruber et al., 2007). There is substantial evidence for
the involvement of histone methylation in neurogenesis.
The Action of Methyltransferases on Embryonic
Neurogenesis
As mentioned in the introduction, during brain development
neural stem cells initially give rise to neurons, and at about
E18 in the mouse there occurs a switch in differentiation
competence toward astrogliogenesis. Probing the mechanism of
this intrinsic switch, Tan et al. (2012) demonstrated that ESET,
an H3K9 methyltransferase previously known to be required for
the maintenance of the pluripotent state in ES cells (Bilodeau
et al., 2009; Yeap et al., 2009; Yuan et al., 2009), is pivotal
for the regulation of the fate competence of NSPCs during
development. Conditional knockout of ESET in the embryonic
forebrain unveiled an intriguing finding: ESET seemed to be
required for the generation of the deep cortical cell lineages
that arise first, but the effects on later superficial cortical
cell lineages was less pronounced. Additionally, the knockout
of ESET led to precocious astrogliogenesis, demonstrated by
markedly increased GFAP staining both in vivo and in NSPCs
in vitro (Tan et al., 2012). The converse experiment of over-
expressing ESET by in utero electroporation showed reduced
astrocytic differentiation. In assessing the mechanism of action of
ESET, the authors demonstrated by ChIP that it directly binds the
promoters of GFAP and Sox9, associated with astrogliogenesis,
repressing their expression by H3K9 tri-methylation. In the
absence of ESET, these genes exhibit less of the H3K9me3
mark, and are over-expressed. On the contrary, many genes
associated with neurogenesis were down regulated in the ESET
knockout brains, hinting toward an indirect regulation by ESET.
Therefore, the methyltransferase ESET is involved in the cell
fate regulation of the embryonic NSPCs, by actively suppressing
astrogliogenesis.
The H3K9 methyltransferase G9a and the related molecule
GLP, appear to function as a constitutive heteromeric complex
to promote H3K9 dimethylation in euchromatic regions leading
to transcriptional repression (Shinkai and Tachibana, 2011).
During the development of the mammalian retina, G9a has been
shown to repress progenitor gene expression, which facilitates
the terminal differentiation of these cells (Katoh et al., 2012).
Indeed, postnatal conditional loss of function of the G9a/GLP
complex causes the de-repression of neural progenitor cell genes,
as well as non-neural genes, in mature neurons resulting in severe
behavioral defects in these animals (Schaefer et al., 2009). It
remains to be determined how the G9a/GLP complex is recruited
to specific loci to promote transcriptional repression, but such
a mechanism would likely be active during the transition from
a proliferating progenitor cell to a post-mitotic differentiated
neuron or glial cell, and may even persist to ensure the
maintenance of repression marks on these progenitor genes in
mature cells.
Polycomb Family Members
Additional evidence for the importance of histone methylation
on the onset of neurogenesis arises from seminal work
on Bmi-1, associated with the Polycomb family of H3K27
methyltransferases (Schuettengruber et al., 2007). Bmi-1−/−
mice exhibit a variety of neurological defects starting from an
early age (van der Lugt et al., 1994). Molofsky et al. (2003)
showed that Bmi-1−/− mice demonstrate decreased self-renewal
and proliferation in both embryonic and postnatal forebrain
NSCs. Bmi-1 enhanced NSC self-renewal and proliferation
partly by blocking p16Ink4a and p19Arf , 2 inhibitors of cyclin-
dependent kinases (Jacobs et al., 1999; Molofsky et al., 2003).
Interestingly, Bmi-1 was required for the proliferation of
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NSCs, but not for that of committed neurogenic or gliogenic
progenitors, revealing a regulatory role upstream in the hierarchy
of neurogenesis.
In a different report Fasano et al. (2007) utilized a lentivirus-
delivered shRNA approach to knockdown the expression of Bmi-
1 in embryonic, perinatal or adult NSCs and their results were
slightly different. Even though they did observe a decrease in
NSC proliferation and self-renewal, the effects of the Bmi-1
knockdown were more pronounced as the age of the mice was
increasing. Therefore, adult NSCs seemed to be more dependent
on Bmi-1 than embryonic NSCs. The authors attributed their
effects to p21 up-regulation upon Bmi-1 knockdown, and when
p21 was also knocked down the phenotype was rescued. Unlike
Molofsky et al., Fasano et al., did not observe a p16Ink4a or
p19Arf up-regulation after Bmi-1 knockdown, and simultaneous
knockdown of Bmi-1, p16Ink4a and p19Arf failed to rescue the
Bmi-1 phenotype.
The differences between the 2 studies can be attributed to the
fact that the knockout mice used by Molofsky et al. might have
had compensatorymechanisms in place since they had to develop
without Bmi-1, while the shRNA approach provides a more acute
decrease in Bmi-1. It is also plausible that the decreased levels of
Bmi-1 produced by an shRNA knockdown cannot recapitulate
the true null phenotype of a Bmi−/− mouse, and the presence of
a remaining minimal amount of protein is sufficient to alter the
observed effects. Additionally, the different mouse backgrounds
used in the 2 studies could have also contributed to the observed
differences.
In a recent report by Gargiulo et al. (2013), Bmi-1 was found
by ChIP/RNA-seq to target p16Ink4a, p19Arf, and p21, along
with an array of additional cdk inhibitors. Gargiulo et al. also
found that Bmi-1 down-regulates multiple members of the BMP
and TGF-β pathways, which are long established to be involved
in inducing differentiation of NSCs into neurons or astrocytes
(Bond et al., 2012; Rodriguez-Martínez and Velasco, 2012).
Therefore, it appears that Bmi-1 enhances the NSC proliferation
and renewal by 2 mechanisms: (i) it suppresses cdk inhibitors,
thus allowing the NSCs to continue cycling and (ii) it suppresses
neurogenic pathways, thus delaying the onset of differentiation.
A schematic demonstration of this model is shown in Figure 3.
The converse experiment, namely, over-expression of Bmi-
1, resulted in an increase in the self-renewal and proliferation
of both embryonic and adult NSCs (Fasano et al., 2009). In
addition, the authors showed that FoxG1, a forebrain-specific
transcription factor (Shen et al., 2006) was necessary for the
Bmi-1—induced increase in NSC self-renewal. This raises the
possibility that FoxG1 is a downstream effector of Bmi-1,
even though over-expression of FoxG1 was less effective at
promoting an increase in NSC self-renewal compared to Bmi-
1 over-expression. Therefore, either Bmi-1 utilizes additional
downstream effectors, or Bmi-1 and FoxG1 operate in different
pathways. Intriguingly, NSC self-renewal was unchanged when
Bmi-1 was over-expressed in embryonic spinal cord NSCs,
which constitutes additional evidence for the notion that the
epigenetic regulation of neurogenesis utilizes divergent pathways
in a region-specific manner.
Trithorax Family Members
In addition to the Polycomb family of transcriptional repressors,
there exists the Trithorax family of transcriptional activators
that operate by methylating H3K4 residues (Schuettengruber
et al., 2007). The Trithorax family member Mll1 (Mixed
lineage leukemia 1), an H3K4 methyltransferase, was reported
to be involved in postnatal neurogenesis in a very interesting
manner (Lim et al., 2009). Mll1 seemed to be necessary for
the induction of Dlx2, an indispensable transcription factor for
FIGURE 3 | The role of the Polycomb protein Bmi-1 in neural stem cell self-renewal. The Polycomb complex trimethylates the regulatory regions of the cdk
inhibitors p16Ink4a, p19Arf, and p21 at the lysine 27 residue of H3. This represses their expression, which allows cell cycle to proceed. In the absence of Bmi-1, the
cdk inhibitors are expressed and block the cell cycle. This decreases the self-renewal capability of the neural stem cells.
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olfactory bulb neuron specification and migration (Long et al.,
2007). NSPCs isolated from the forebrain of postnatal mice in
which Mll1 had been conditionally knocked out survived and
proliferated normally, but gave rise to significantly less neurons
than controls. Gliogenesis was not affected. Similar phenotypes
were observed in vivo. Therefore, Mll1 is required specifically
for neuronal differentiation of forebrain NSPCs, unlike other
epigenetic regulators that we reviewed above that are required for
differentiation into all 3 lineages. Surprisingly, Mll1 did not act by
catalyzing an H3K4 methylation event, but rather by recruiting
an undefined H3K27 demethylase at the Dlx2 promoter. Since
H3K27 methylation is inhibitory for gene expression, such
H3K27 demethylase would activate transcription. Therefore, just
as has been observed in other systems (Schuettengruber et al.,
2007), it appears that members of the conserved Polycomb
and Trithorax families of methyl-transferases co-operate to
regulate neurogenesis. The Polycomb member Bmi-1 ensures
that the NSCs remain in cycle for as long as needed to generate
enough progeny and then passes the baton to the Trithorax
member Mll1 which overviews neuronal differentiation. How
this strict temporal pattern of activity of these epigenetic factors
is controlled remains to be elucidated.
Histone Demethylases
An independent report by Jepsen et al. (2007) showed
that JMJD3/KDM6B, a putative histone demethylase, steers
interneuron differentiation in NSPCs from the mouse embryonic
cortex. JMJD3/KDM6B contains a Jumonji C domain, which
is responsible for its histone demethylase activity (Klose et al.,
2006). A mutant JMJD3/KDM6B lacking this domain was
unable to induce interneuron differentiation. Through an
in vitro demethylation assay, it was shown that JMJD3/KDM6B
specifically demethylates H3K27me3, therefore causing a de-
repression of the target genes, many of which appear to be
neuronal. Treatment of NSCs with retinoic acid, a known
inducer of neuronal differentiation (Ribes et al., 2006), induced
binding of JMJD3/KDM6B to the Dlx5 promoter and reduction
in the H3K27me3 levels as evidenced by ChIP. Dlx5 is
expressed in differentiated interneurons (Anderson et al., 1997).
JMJD3/KDM6B is normally suppressed by Nuclear Co-repressor
2 (NcoR2 or SMRT), a protein involved in a multitude of
developmental processes (Mottis et al., 2013). Knocking out
SMRT resulted in significant alterations in the forebrain of
mouse embryos as well as decreased proliferation and increased
differentiation of embryonic cortex NSPCs into neurons and
astrocytes. RA signaling was necessary for the increased neuronal
differentiation of the SMRT−/− cells and JMJD3/KDM6B was
significantly up regulated upon the knockout. More recently,
it has been demonstrated that JMJD3/KDM6B is actually
required for proper neurogenesis (Park et al., 2014). Whether
JMJD3/KDM6B is the same H3K27 demethylase that is recruited
by Mll1 in the study of Lim et al. is unknown and will require
further studies, but it has been shown in other cellular contexts
that JMJD3/KDM6B and Mll1 indeed interact (Shi et al., 2014).
In addition to JMJD3/KDM6B, recent evidence indicates that
histone demethylases JMJD2A/KDM4A and JMJD2C/KDM4C
are important PTM enzymes that contribute to neurogenesis
(Cascante et al., 2014). Cascante et al. demonstrated that
these enzymes are required for demethylating BDNF regulatory
regions at H3K9 in response to the HDAC inhibitor VPA, thus
inducing its expression. At the same time, these enzymes are
required for demethylation of GFAP exonic regions at H3K36,
leading to a blockade of astrogliogenesis. How this differential
specificity for methylated lysine is achieved remains to be
identified and may involve different cofactors for each promoter.
The authors showed that knockdown of JMJD2A/KDM4A
and JMJD2C/KDM4C by siRNA in embryonic cortical NSPCs
led to precocious astrogliogenesis and decreased neurogenesis
associated with increased cell death. These data support previous
results from analyses of a different histone demethylase, namely,
JHDM1D. Huang et al. (2010) demonstrated that JHDM1D is
necessary for neural specification of ES cells, by demethylating
regulatory regions of FGF4. Similar to JMJD2A/C, this enzyme
appears to be bi-specific: it removes methyl residues from both
H3K9 and H3K27.
In conclusion, it appears that the neuronal specification of
an NSPC in addition to methyl transferase activities requires
the presence of multiple histone demethylases that de-repress
neuronal commitment genes that were silent in the progenitors,
while at the same time suppressing alternative fates.
Histone Arginine Methylation
Apart from histone methylation on lysine residues, histone
methylation on arginine residues has also been implicated
in the regulation of neurogenesis. In general, symmetric
dimethylation (symbolized as me2s) of an arginine residue
is associated with transcriptional repression of the respective
gene, while asymmetric dimethylation (me2a) is associated
with transcriptional activation (Xu et al., 2010; Di Lorenzo
and Bedford, 2011; Chittka et al., 2012). Chittka et al. (2012)
reported that the transcription factor Schwann cell factor 1
(SC1, also known as PRDM4) controls the onset of neurogenesis
from embryonic NSPCs by recruiting the histone arginine
methyltransferase PRMT5. In embryonic NSPCs cultured
in vitro, SC1 was only expressed in non-terminally differentiated
mitotically active progenitors, but not in TuJ1+ or GFAP+ cells.
The levels of SC1 staining decreased over time in culture, along
with the increase in differentiation. Silencing of SC1 by siRNA
induced precocious neuronal differentiation, and decreased
BrdU incorporation, while over-expression of SC1 increased
the proportion of Nestin positive cells in the embryonic NSPC
cultures. Through a series of immunoprecipitation experiments,
the authors showed that SC1 interacts with the methyltransferase
PRMT5 through its N-terminal domain. The presence of the N-
terminus of SC1 was necessary to achieve the increase in Nestin+
cells after over-expression in neural stem cell cultures, indicating
that PRMT5 may be necessary for the effect. Additionally,
both embryonic NSCs and sections of E10.5 cortex, showed
high levels of expression of both PRMT5 and SC1 and very
frequent H4R3me2s modifications. The latter is the symmetrical
di-methylation catalyzed by PRMT5. The authors also showed
that over-expression of SC1 containing the N-terminus, led to a
down regulation in the expression of the promitotic genes Bub1b
and cyclinB. Conversely, siRNA knockdown of SC1 led to an
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up-regulation of Bub1b and cyclinB. High levels of promitotic
genes have been shown to be required for proper asymmetric
division (Tio et al., 2001), raising the possibility that SC1 delays
the onset of neurogenesis by impeding asymmetric division of
neural stem cells which would give rise to committed progenitors.
Nevertheless, more research is needed to directly demonstrate
that PRMT5 is necessary for these effects. Interestingly,
differentiated neurons correlated with H4R3me2a marks, while
undifferentiated precursors correlated with H4R3me2s marks
(Chittka, 2010). Therefore, the methylation status of H4R3
appears to function as a binary switch that changes its position
along with neuronal differentiation. Whether the epigenetic
switch has a causative role in neuronal differentiation or it is a
consequence of that differentiation remains to be elucidated.
Elucidating a Putative Histone Methylation Code of
Neurogenesis
Despite the plethora of convincing evidence demonstrating that
histone methylation is involved in neurogenesis, correlating
specific methylation marks with gene expression or repression
is still difficult. This complexity was demonstrated in a report
by Popova et al. (2012). The authors monitored the presence
of H3K4me2 and H3K27me3 during pre- and postnatal retinal
development and attempted to correlate that with the expression
level of individual genes. No simple correlation was identified as
for some genes increases in expression correlated with increased
H3K4me2 and decreased H3K27me3, while for others they did
not. This demonstrates that the particular epigenetic marks
cannot be universally used as predictors of gene expression
or repression, and that the specific histone modifications that
regulate expression vary between genes. Interestingly, the genes
with similar correlations between expression and presence of
the 2 epigenetic marks could be grouped with gene ontology.
Additionally, the authors were able to identify a specific
epigenetic signature that could predict the identity of a gene as
photoreceptor-specific. Thus, specific gene families may share
common epigenetic mechanisms of expression regulation, and
the identification of these mechanisms could generate novel,
sensitive genetic tools for screening of genes associated with the
development of specific systems.
Combining Histone Acetylation and Methylation: The
Example of CtBPs
We have reviewed histone acetylation and histone methylation as
distinct processes; however, there are examples of proteins that
combine these 2 activities. C-terminal binding proteins (CtBPs)
repress transcription by recruiting both HDAC and H3K9
methyltransferase activities to the promoters (Hildebrand and
Soriano, 2002; Shi et al., 2003). Dias et al. (2014) demonstrated
that CtBPs are indispensable for repressing neurogenesis in the
roof plate (RP), a BMP-secreting structure which is responsible
for dorsoventral patterning of neural cells within the neural
tube (Liem et al., 1995, 1997; Lee et al., 2000). The authors
demonstrated that there is an oxygen gradient within the
neural tube, with the RP receiving higher oxygen levels than
the neurogenic regions. This leads to higher concentrations of
NADH, the reduced form of NAD+, within the RP region.
NADH interacts with CtBPs (Kim et al., 2005), increasing
their transcriptional repressive function. This leads to CtBPs
repressing the expression of Math1, a proneural transcription
factor, specifically in the higher oxygen environment of the
RP, so as to prevent this region from generating neural tissue.
Interestingly, CtBPs also bound promoter elements of Hes1,
which inhibits neurogenesis, following an inverse correlation
with oxygen levels: CtBPs repressed Hes1 expression in the lower
oxygen environment of the neural tube. At higher oxygen levels,
CtBPs are released from the Hes1 promoter, which enables a
blockade of neurogenesis in the RP.
CtBPs have also been shown to be involved in neurogenesis by
inhibiting Notch signaling targets in the absence of Notch ligand
(Oswald et al., 2005). Data from Xenopus laevis and mammalian
cell lines have shown that the transcriptional repressor SHARP
is required for proper inactivation of Notch signaling (Garriga-
Canut et al., 2001; Oswald et al., 2002, 2005). It has been
proposed that SHARP blocks transcription by two independent
mechanisms, one of which is sensitive to HDAC inhibitors
(Garriga-Canut et al., 2001). It was eventually discovered
that SHARP interacts with CtBPs and that this interaction is
necessary for its ability to suppress Notch signaling and promote
differentiation (Oswald et al., 2005). Therefore, CtBP complexes
are multimodal histone modifiers that appear to be involved in
neurogenesis through diverse pathways.
SPECIFIC CONSIDERATIONS
Initiation of Chromatin Modifications in the
Context of Neurogenesis
What is it that triggers the initiation of chromatin modifications
associated with neurogenesis? It appears that known signals
that induce neurogenesis under certain contexts, such as FGFs
(Kengaku and Okamoto, 1993), neurotrophins (Bartkowska
et al., 2007), bone morphogenic proteins (BMPs) (Andersson
et al., 2011; Bond et al., 2012) and other members of the
transforming growth factor β (TGFβ) (Rodriguez-Martínez and
Velasco, 2012) family also trigger the initiation of histone PTMs.
In the example of CREB that was reviewed above, activation
is controlled by phosphorylation of serine-133. CREB can be
activated by a variety of cellular pathways, including the cAMP
pathway, the PI3 kinase pathway, the MAP kinase (MAPK)
pathway, or even in response to increased intracellular Ca2+
(Dworkin and Mantamadiotis, 2010). Therefore, an array of
signaling molecules involved in neurogenesis also leads to CREB
activation. Nerve growth factor (NGF), platelet-derived growth
factor (PDGF) and FGFs are just some examples of factors
that activate the PI3 kinase pathway (Kapeller and Cantley,
1994; Brader and Eccles, 2004). Similarly, MAPK signaling
is activated by FGFs (Thisse and Thisse, 2005) and insulin-
like growth factor 1 (IGF-1) (Bateman and McNeill, 2006)
among others. Thus, a functional link between secreted signals
involved in neurogenesis and CREB activation can be established.
Additionally, the fact that CREB can be activated in response to
elevated intracellular Ca2+ and cAMP provides a link between
mature neuronal activity and CREB recruitment to chromatin.
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Interestingly, CREB activation by Ca2+ (and not the other
pathways) leads to the phosphorylation of 2 additional serine
residues, which may alter its target specificity (Kornhauser et al.,
2002). In an alternate example, Estarás et al. (2012) showed that
Smad3 recruits JMJD3/KDM6B to neuronal promoters in NSCs.
This establishes a connection between JMJD3/KDM6B H3K27
demethylase activity and the TGFβ pathway.
It appears therefore, that known exogenous neurogenic
signals are sufficient to induce post-translational modifications
of transcription factors, which leads to recruitment of histone
modifying factors to the chromatin, and thereby changes in
chromatin charge and conformation associated with increased
gene expression of neurogenic factors. This functions as an
additional argument for the notion that chromatin modifications
are an essential component of the mechanisms regulating
neurogenesis.
Tissue Specific Effects of Global
Regulators
Most histone PTM regulators may function globally in the
genome. An obvious question that arises from that observation
is how a master regulator can perform a tissue specific function.
There are several ways that such neurogenesis-specific function
of factors with assumed general functions can be achieved. As
described in the example above, exogenous signals can influence
ubiquitously expressed transcription factors in specific ways
resulting in signaling-context-specific recruitment of histone
modifying factors to localized regions of the chromatin. In
addition, the signature of the pathway that activates a global
regulator can be “stamped” on it via specific modifications, which
can affect the selection of the downstream targets.
Exogenous signals may also affect the levels of histone
modifying factors in the cell. For example, JMJD3/KDM6B
expression is highly regulated by retinoic acid, and thus factors
with general function may not always be expressed evenly in
different cell types, including progenitors. In fact, many factors
with general function, including CBP, HDACs, HDMs etc., may
not always be ubiquitously expressed and tissue- and cell-specific
expression of variants of chromatin-modifying factors have been
reported (for example neuro-specific BAFs, Olave et al., 2002).
It is further necessary to consider the combination of factors
expressed in a certain cell, as factors with similar function
in different cell types may utilize cell-specific adaptors and/or
chaperones. Such strategies are utilized by, for example, the
arginine methyltransferase PRMT5 (reviewed above), that has
been involved in various systems in addition to neurogenesis,
such as primordial germ cells, embryonic stem cells and
erythrocyte progenitors (Ancelin et al., 2006; Saitou, 2009; Zhao
et al., 2009; Xu et al., 2010), always having the function of
maintaining cells in an undifferentiated state. In this case, the
global gene expression regulator gets recruited within specific
cell types by different adaptor proteins. For neural stem cells, the
adaptor protein seems to be the transcription factor SC1, while
for primordial germ cells the adaptor protein is known to be
Blimp1 (Ancelin et al., 2006), as shown in Figure 4.
While these examples appear straightforward, it is also
important to keep in mind that there is cross-talk among the
FIGURE 4 | Neural specific roles of universally expressed histone
modulators as exemplified by the arginine methyltransferase PRMT5.
In germ cells, PRMT5 forms a complex with the transcription factor Blimp1
and symmetrically dimethylates regulatory regions of somatic genes, which
inhibits their expression. This ensures maintenance of the germ cell fate. In
neural stem cells, PRMT5 forms a complex with the transcription factor SC1
and suppresses the expression of neuronal genes, which delays the onset of
differentiation and maintains the neural stem cell state.
histone modifications themselves. As the modifications alter
chromatin charge and conformation, they can facilitate or
hinder secondary and even tertiary histone modifications and
thereby directly influence the recruitment of factors to promote
neurogenesis.
Chromatin Modification Complexes
Encompassing “Write,” “Read,” and
“Erase” Functions, that have a Role in
Neurogenesis
Considering each histone modification enzyme in isolation
obscures the true picture of how these proteins are regulated.
Usually, chromatin regulation operates through complexes that
integrate the many aspects of epigenetics, in addition to histone
PTMs.
In the context of neurogenesis, one of the most well
established complexes is the one that converges on element-1
silencing transcription factor/neuron-restrictive silencing factor
(REST/NRSF) (Qureshi et al., 2010; Jobe et al., 2012). REST is
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a transcription factor that recognizes the repressor element 1
(RE1) and was long believed to only function as a transcriptional
repressor of neuronal genes in non-neural tissues. REST
knockouts are embryonic lethal with a range of neural and
non-neural malformations. REST can be induced by a variety
of signals and has in addition been suggested to induce
genes involved in neurogenesis and participate in neuronal
differentiation and maturation (Qureshi et al., 2010). Similar
to other zinc finger transcription factors, REST functions as
a central node that recruits a massive array of epigenetic
modifiers. An interesting key to the mechanisms underlying
the many functions of REST came with the discovery of
an interacting regulatory protein, Co-REST (Andrés et al.,
1999). Co-REST is associated with the CtBP complex (see
above) and is therefore a primary example of the plethora
of enzymes with various functions recruited to DNA and
thus chromatin by single transcription factors. These proteins
include “writers” such as histone methyltransferases, “erasers”
such as histone deacetylases, and “readers” such as methyl-
DNA binding proteins. Additionally, REST recruits non-coding
RNAs, components of the SWI/SNF remodeling complex and
various adaptor proteins with a wide range of activities (Yoo
and Crabtree, 2009). Therefore, REST forms signal- and cell-
context specific complexes that make use of many of the known
epigenetic mechanisms.
Additional examples of such multifunctional epigenetic
complexes are the ones formed by the H3K27 methyltransferases
of the Polycomb group. We reviewed the role of Bmi-1 in
neurogenesis above. Bmi-1 does not operate in isolation, but
rather as part of a multi-protein complex called PRC1 (Polycomb
Repressive group Complex 1). The complex exists in many
alternative forms that contain H3K27me3 binding proteins
(“readers”), histone ubiquitin ligases (“writers”), and additional
histone binding proteins as well as activity regulators and
proteins of unknown function (Luis et al., 2012; Aloia et al.,
2013). This enzyme complex can either operate in isolation,
or together with a different complex of the Polycomb family,
PRC2. PRC2 contains the H3K27 methyltransferase enhancer of
zeste 1 or 2 (EZH1 or EZH2, “writers”), along with H3K27me3
binding proteins, additional histone and DNA binding proteins
(“readers”) and enzymatic regulators (Margueron and Reinberg,
2011; O’Meara and Simon, 2012). PRC2 also has a pivotal role
in neurogenesis, as has been demonstrated by studies on EZH2
and other components of the complex (Pasini et al., 2007; Pereira
et al., 2010; Chou et al., 2011). In addition to the core components
of the complexes, their recruitment to chromatin is dependent
on DNA methylation and non-coding RNAs (Margueron and
Reinberg, 2011; Jobe et al., 2012; Aloia et al., 2013). These
complexes therefore constitute another example of integration of
multiple epigenetic mechanisms within one pathway.
It is becoming increasingly evident that the interactions
between different epigenetic modifications play key roles in
cellular differentiation, and that the variable composition of
many poly-enzymatic complexes is a way of conferring tissue
specificity. Additional research in this field will improve our
understanding of the epigenetic component of neurogenesis
and may reveal novel mechanisms of initiation of chromatin
remodeling. Furthermore, how these histone PTMs are sustained
for a certain developmental interval without being removed
prematurely remains elusive.
Histone Dynamics: An Unchartered
Territory for Understanding Chromatin
Regulation of Neurogenesis
Even though a great deal of research has focused on the
effects of histone PTMs, an interesting direction would be
looking into the impact of histone abundance and turnover on
neurogenesis. Histones are relatively stable proteins, and their
half-life in non-dividing brain cells was found to average 159
days (Commerford et al., 1982). The amount of histones within
a cell is tightly regulated, since a histone insufficiency would
impede the efficient packaging of DNA and lead to cell death,
while an excess of histones can cause chromatin aggregation
due to their highly positive charge (Steger and Workman, 1999;
Nelson et al., 2002; Ye et al., 2003; Gunjan et al., 2006). The
dynamics of histone synthesis differ between diving and non-
diving cells, since dividing cells have to couple histone with
DNA synthesis at the S-phase (Gunjan et al., 2006). Thus, non-
terminally differentiated cells such as NSPCs will synthesize
histones at a faster rate than terminally differentiated neurons.
Accordingly, a cathepsin-dependent mechanism for histone H3
turnover has been described in differentiating ES cells (Duncan
et al., 2008). Additionally, there is evidence that histone turnover
differs between actively transcribed and silent regions of the
genome, as well as that epigenetic modification can alter histone
turnover (Henikoff, 2008; Deal et al., 2010). Most of the effects
of histone PTMs in the literature have been assessed within
the conceptual framework of stable nucleosomes and do not
take into account potential effects on histone dynamics. Indeed,
the latter could prove to be a major mechanism of action of
epigenetic modifications, especially in light of recent advances
in techniques to measure histone turnover (Deal et al., 2010)
and findings of aberrant histone turnover in patients with
the neurodevelopmental disorder Rett syndrome (Lilja et al.,
2013). Whether the histone abundance in and of itself plays a
role in cellular differentiation is a consideration that has not
been addressed in existing research. It would be interesting to
investigate the consequences of enhanced or suppressed histone
synthesis on NSPC behavior.
CONCLUSION
Histone PTMs are an essential component of both embryonic
and adult neurogenesis. Some of them are induced by neurogenic
signals and appear to be under the control of specific signaling
pathways that are involved in neurogenesis in diverse ways.
More research is needed to decipher the exact pathways that
trigger histone modification by other enzymes, as well as the
mechanisms that lead to the tissue-specific effects of global
modulators. It is becoming clear that many of these answers lie in
the intricate albeit specific crosstalk between different epigenetic
modifiers within and among enzymatic complexes. Future
research into how the specific signaling networks influence the
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chromatin modifiers and their interactions in specific aspects of
NSPC differentiation and other cellular events will increase our
understanding of the process of neurogenesis and the pathologies
underlying neurodevelopmental and psychiatric disorders.
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